Lilly’s Alzheimer’s struggles continue as preclinical asset fails phase III
AstraZeneca says cancer drug Imfinzi improves survival chances in late-stage trial
Bayer plans to double down on US pharma R&D in 2023
Most innovative medical device companies in 2023
*please scroll down for all the latest news*
